PharmaCyte Biotech, Inc. (PMCB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 20.7M | 23.02M | 19.11M | 22.38M | 16.96M | 21.33M | 32.88M | 50.44M | 61.51M | 73.75M | 74.75M | 68.15M |
| Cash & Short-Term Investments | 20.54M | 15.61M | 13.44M | 15.54M | 16.76M | 20.84M | 32.64M | 50.18M | 61.21M | 73.43M | 74.66M | 68.04M |
| Cash Only | 20.17M | 15.41M | 13.18M | 15.17M | 16.38M | 20.84M | 32.64M | 50.18M | 61.21M | 73.43M | 74.66M | 68.04M |
| Short-Term Investments | 372.25K | 201.19K | 261.85K | 366.32K | 372.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 5M | 4.61M | 3.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 158.66K | 2.42M | 1.06M | 3.14M | 207.36K | 493.21K | 240.23K | 259.8K | 297.76K | 323.19K | 88.65K | 0 |
| Total Non-Current Assets | 35.18M | 32.95M | 26M | 32.79M | 26.87M | 33.77M | 37.32M | 9.46M | 9.85M | 5.13M | 5.13M | 5.13M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M | 3.55M | 3.55M | 3.55M | 3.55M |
| Long-Term Investments | 33.62M | 31.4M | 24.45M | 22.47M | 25.31M | 24.86M | 29.12M | 7.91M | 6.29M | 1.57M | 1.57M | 1.57M |
| Other Non-Current Assets | 7.69K | 7.69K | 7.69K | 8.77M | 7.69K | 7.36M | 6.65M | 7.69K | 7.69K | 7.69K | 7.69K | 7.69K |
| Total Assets | 55.87M | 55.98M | 45.11M | 55.17M | 43.83M | 55.1M | 70.19M | 59.9M | 71.36M | 78.88M | 79.88M | 73.28M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 27.48% | 1.59% | -35.73% | -7.91% | -38.58% | -30.15% | -12.13% | -18.25% | -8.46% | -4.21% | -8.59% | -19.14% |
| Total Current Liabilities | 1.68M | 1.58M | 1.06M | 2.91M | 1.19M | 4.78M | 7.47M | 7.42M | 7.54M | 5.24M | 1.52M | 586.58K |
| Accounts Payable | 1.2M | 1.02M | 465.21K | 399.2K | 484.95K | 348.6K | 553.95K | 389.37K | 484.2K | 126.16K | 718.13K | 128.28K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 478.15K | 35.39K | 0 | 0 | 709.44K | 4.08M | 6.74M | 6.73M | 6.9M | 4.96M | 665.25K | 345.41K |
| Current Ratio | 12.33x | 14.60x | 18.01x | 7.68x | 14.20x | 4.47x | 4.40x | 6.80x | 8.16x | 14.08x | 49.24x | 116.18x |
| Quick Ratio | 12.33x | 14.60x | 18.01x | 7.68x | 14.20x | 4.47x | 4.40x | 6.80x | 8.16x | 14.08x | 49.24x | 116.18x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 14.79M | 17.84M | 458K | 363K | 2.38M | 6.87M | 9.68M | 12.97M | 14.93M | 15.57M | 18.88M | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 14.79M | 17.84M | 458K | 363K | 2.38M | 6.87M | 9.68M | 12.97M | 14.93M | 15.57M | 18.88M | 0 |
| Total Liabilities | 16.47M | 19.42M | 1.52M | 3.28M | 3.58M | 11.65M | 17.15M | 20.39M | 22.47M | 20.81M | 20.4M | 586.58K |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -20.17M | -15.41M | -13.18M | -15.17M | -16.38M | -20.84M | -32.64M | -50.18M | -61.21M | -73.43M | -74.66M | -68.04M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | -240423.80x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 38.99M | 36.14M | 43.59M | 51.89M | 40.25M | 43.45M | 53.04M | 39.51M | 48.89M | 58.07M | 59.48M | 72.69M |
| Equity Growth % | -3.14% | -16.83% | -17.82% | 31.32% | -17.68% | -25.17% | -10.83% | -45.64% | -36.6% | -28.35% | -31.07% | -19.16% |
| Book Value per Share | 4.21 | 5.32 | 6.41 | 7.64 | 5.78 | 5.69 | 6.74 | 4.73 | 5.68 | 6.62 | 11.49 | 14.04 |
| Total Shareholders' Equity | 38.99M | 36.14M | 43.59M | 51.89M | 40.25M | 43.45M | 53.04M | 39.51M | 48.89M | 58.07M | 59.48M | 72.69M |
| Common Stock | 2.6K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.17K | 2.16K |
| Retained Earnings | -100M | -100.75M | -93.33M | -84.97M | -96.72M | -93.67M | -92.2M | -115.63M | -116.97M | -116.35M | -119.46M | -115.96M |
| Treasury Stock | -45.01M | -44.61M | -44.61M | -44.61M | -44.43M | -44.21M | -42.79M | -42.04M | -40.85M | -40.45M | -40.02M | -13.56M |
| Accumulated OCI | -21.54K | -24.13K | -23.75K | -23.87K | -24.49K | -23.27K | -23.33K | -23.51K | -23.07K | -24.14K | -22.55K | -23K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |